Search

everythinglearnresearchcommunity

for

Search:↓

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

BST2 protein and certain T cells increase in early alopecia areata.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Excimer laser therapy can be an alternative for treating superficial morphea when topical steroids don't work.

Certain immune cells in the skin can stop hair from growing.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Early regulatory T cells are crucial for normal skin pigmentation.

Skin issues can indicate immune system problems.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

RACB in barley is crucial for cell polarity and nucleus positioning, aiding fungal infection.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.